Pα+ Psychedelic Bulletin #218: FDA’s Farchione Says Psychedelic INDs Are “a Third” of Her Workload; Ipsos/Psychedelic Alpha Poll; Reunion Eyes Single Phase 3 in PPD; America’s 10 Million Microdosers

FDA’s Farchione Says Psychedelic INDs Now “a Third” of Her Workload; NIDA’s Volkow Questions Schedule I Placement • Ipsos/Psychedelic Alpha Poll Probes Americans’ Attitudes Towards Psychedelics • RAND Estimates 10 Million U.S. Adults Microdosed Last Year • Reunion Targets Single Phase 3 Path in PPD; Releases Additional Phase 2 Data • MindMed Rebrands to Definium, Launches LSD Education Push • Interview: Independent Psychedelic Evidence Assessment Working Group • New Jersey Governor Signs $6M Psilocybin Pilot Program Into Law • and more…